Help safeguard and ensure abortion care — give today.

background
Photo by Daniel H. Tong on Unsplash

Association for Reproductive Health Professionals Annual Meeting

Date
September 30th, 2007

Gynuity staff members gave an oral presentation on results from a medical abortion study in Moldova, a poster presentation presenting a US-based study on non-vaginal routes of misoprostol administration following mifepristone for medical abortion, and a Lunch and Learn session on the use of misoprostol for self-induced abortion.

Randomized Study of Sublingual and Oral Misoprostol following 200 mg Mifepristone for Abortion up to 63 Days Gestation in Moldova
S. Raghavan, R. Comendant, B. Winikoff

The Potential of Two Non-vaginal Routes of Misoprostol Administration Following Mifepristone for Medical Abortion up to 63 Days Gestation (poster)
I. Dzuba, C. Shannon, T. Britton, M.D. Creinin, A. Goldberg, R. Hanson, M. Howe, E.S. Lichtenberg, M. Molaei, L. Prine, B. Winikoff

Exploring the Use of Misoprostol for Self-induced Abortion Worldwide: Observations, Reflections, and Discussion (Lunch and Learn session)
Presenters: M. Zurek, B. Winikoff, A.M. Foster, J. Gonzalez-Rojas